ProKidney Corp (PROK)

NASDAQ
Currency in USD
4.000
+3.394(+559.52%)
Real-time Data·
PROK Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
Fair Value
Day's Range
1.0204.450
52 wk Range
0.4604.450
Key Statistics
Edit
Prev. Close
0.607
Open
1.27
Day's Range
1.02-4.45
52 wk Range
0.46-4.45
Volume
298.08M
Average Volume (3m)
1.13M
1-Year Change
-73.02%
Book Value / Share
-7.71
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PROK Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
4.000
Upside
0.00%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

ProKidney Corp News & Analysis

Show more

ProKidney Corp Company Profile

ProKidney Corp., a clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States. Its lead product candidate, rilparencel, includes autologous selected renal cells (SRC) in Phase 3 and Phase 2 clinical studies in subjects with moderate to severe chronic kidney disease and diabetes. The company also develops a cryopreserved version of rilparencel that allows for long-term product preservation to be used in Phase 2 and 3 trials of rilparencel. ProKidney Corp. was founded in 2015 and is headquartered in Winston-Salem, North Carolina.

Compare PROK to Peers and Sector

Metrics to compare
PROK
Peers
Sector
Relationship
P/E Ratio
−2.6x−2.4x−0.5x
PEG Ratio
0.310.010.00
Price/Book
−0.2x2.1x2.6x
Price / LTM Sales
580.2x4.2x3.0x
Upside (Analyst Target)
-180.7%49.2%
Fair Value Upside
Unlock4.1%7.4%Unlock

Analyst Ratings

3 Buy
2 Hold
1 Sell
Ratings:
6 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 4.000

Earnings

Latest Release
May 12, 2025
EPS / Forecast
-0.13 / -0.16
Revenue / Forecast
2.30M / --
EPS Revisions
Last 90 days

PROK Income Statement

People Also Watch

5.67
TNGX
+4.48%
2.200
BROGF
+0.46%
1.4900
BON
+6.43%
0.42
YAAS
-5.70%
6.728
LIMN
-2.92%

FAQ

What Is the ProKidney (PROK) Stock Price Today?

The ProKidney stock price today is 4.00

What Stock Exchange Does ProKidney Trade On?

ProKidney is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for ProKidney?

The stock symbol for ProKidney is "PROK."

What Is the ProKidney Market Cap?

As of today, ProKidney market cap is 177.53M.

What Is ProKidney's Earnings Per Share (TTM)?

The ProKidney EPS (TTM) is -0.60.

When Is the Next ProKidney Earnings Date?

ProKidney will release its next earnings report on 06 Aug 2025.

From a Technical Analysis Perspective, Is PROK a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has ProKidney Stock Split?

ProKidney has split 0 times.

How Many Employees Does ProKidney Have?

ProKidney has 204 employees.

What is the current trading status of ProKidney (PROK)?

As of 08 July 2025, ProKidney (PROK) is trading at a price of 4.00, with a previous close of 0.61. The stock has fluctuated within a day range of 1.02 to 4.45, while its 52-week range spans from 0.46 to 4.45.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.